NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beam vs. X-Ray: which radiation is safer for advanced throat cancer?
Disease control Recruiting nowThis study compares two types of radiation therapy for people with advanced nasopharyngeal cancer (a type of throat cancer). Participants will receive chemotherapy and immunotherapy along with either proton therapy or standard X-ray radiation. The goal is to see which approach ca…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Man Hu • Aim: Disease control
Last updated May 17, 2026 02:33 UTC
-
New hope for Tough-to-Treat nasopharyngeal cancer: targeted drug trial launches
Disease control Recruiting nowThis study tests a new drug called HLX43 in 70 people with advanced nasopharyngeal cancer that has come back or spread and no longer responds to standard treatments. The drug targets a protein on cancer cells to deliver a toxin directly. The goal is to see if it can shrink tumors…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New radiation strategy aims to cut side effects in throat cancer without sacrificing cure
Disease control Recruiting nowThis phase 3 trial tests whether giving radiation only to the parts of the neck where cancer has spread (instead of the whole neck) can reduce side effects like thyroid, throat, and muscle damage, while still preventing cancer from coming back. About 462 adults with nasopharyngea…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Double immune attack: new combo therapy targets hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests a combination of two immune-boosting drugs (iparomlimab and tuvonralimab) plus a targeted antibody (nimotuzumab) in 41 adults with recurrent or metastatic nasopharyngeal carcinoma that worsened after standard first-line chemotherapy. The goal is to see if this tr…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Could less radiation be just as effective for advanced nasal cancer?
Disease control Recruiting nowThis study tests whether using a smaller radiation area after full-dose chemotherapy and immunotherapy works as well as the standard larger radiation area for people with nasopharyngeal cancer that has spread. The goal is to maintain cancer control while reducing side effects. Ab…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Could less radiation be better? new trial for advanced throat cancer
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer (a type of throat cancer) whose tumors shrank or disappeared after initial chemotherapy and immunotherapy. It tests whether a lower dose of radiation, combined with more chemo and immunotherapy, works as well as the sta…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (Becotatug vedotin) plus immunotherapy (sintilimab) and standard chemoradiation works better than current treatment for high-risk nasopharyngeal carcinoma. About 266 adults with advanced, non-spread cancer will be randomly assigned to e…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New combo therapy offers hope for hard-to-treat nose cancer
Disease control Recruiting nowThis study tests a new treatment for people whose nasopharyngeal cancer has come back and cannot be removed with surgery. The treatment uses a special pattern of low and high dose radiation along with an immunotherapy drug (anti-PD-1) to shrink tumors while protecting healthy tis…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
New inhaler aims to ease chemo mouth pain for cancer patients
Symptom relief Recruiting nowThis study tests if a drug called Sapylin, given through an inhaler, can prevent or reduce painful mouth sores caused by chemotherapy and radiation in people with nasopharyngeal cancer. About 180 adults with advanced cancer will be randomly assigned to receive either Sapylin or a…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
New PET scan could personalize nasopharyngeal cancer treatment
Knowledge-focused Recruiting nowThis study tests whether a special PET scan can detect a protein called SSTR2 on nasopharyngeal cancer tumors. Ten adults with EBV-related nasopharyngeal cancer will get the scan before and after starting chemotherapy or chemoradiation. The goal is to see if this imaging method c…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC